Senior Research Analyst
Chris provides our investment teams with valuable insight across all healthcare sectors globally, specialising in regulatory affairs and biopharmaceuticals.
He started his finance career at Morgan Stanley, securing a European-focused pharmaceutical analyst role in 2011 after completing an internship with the firm a year earlier. After three years, he joined long/short equity hedge fund Kola Capital as a Senior Analyst before going on to work for Stifel in 2017 as a healthcare specialist.
Chris holds a first-class bachelor’s degree in Physiological Sciences from Oxford University.